Docetaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer.
- Author:
Seok Bong JEON
1
;
Byung Min AHN
;
Jun Ho MUN
;
Woo Jin SUNG
;
Dong Hwan KIM
;
Jong Gwang KIM
;
Tae Bong KIM
;
Ho Young JUNG
;
Wan Sik YU
;
Sang Kyun SOHN
;
Kyu Bo LEE
Author Information
- Publication Type:Original Article
- Keywords: Docetaxel; Cisplatin; Chemotherapy; Gastric cancer
- MeSH: Adenocarcinoma; Cisplatin*; Drug Therapy; Drug Therapy, Combination*; Febrile Neutropenia; Humans; Neutropenia; Stomach Neoplasms*
- From:Korean Journal of Medicine 2005;68(6):672-677
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: We evaluated the efficacy and toxicity of docetaxel plus cisplatin combination as first-line chemotherapy for advanced gastric cancer. METHODS: Patients with metastatic or recurrent gastric adenocarcinoma, performance score
